PREFORMED LINE PRODUCTS CO·4

Feb 6, 5:28 PM ET

Morcos Assaad A 4

4 · PREFORMED LINE PRODUCTS CO · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Preformed Line Products (PLPC) VP Assaad Morcos Receives 407 Shares

What Happened

  • Assaad Morcos, Vice President, US Manufacturing at Preformed Line Products Co. (PLPC), was issued 407 shares on February 4, 2026. The transaction is reported as an award/grant (derivative acquisition) at $0.00 per share — these were restricted stock units (RSUs) converted into common stock, not a market purchase.

Key Details

  • Transaction date and price: 2026-02-04; 407 shares acquired at $0.00 per share (award/derivative).
  • Shares owned after transaction: Not disclosed in the provided filing excerpt.
  • Footnotes of note:
    • F1: The award represents RSUs converted into common stock on a one-for-one basis.
    • F2: The RSUs vest 3 years from the grant date (vesting terms).
    • F3: Separate disclosure: on Dec 11, 2024 the reporting person was granted 7,500 options with a staggered vesting schedule (3,750 vested 12/11/2025; 1,875 vest 12/11/2026; 1,875 vest 12/11/2027) and a 10‑year term.
  • Filing timeliness: Report filed Feb 6, 2026 for a Feb 4, 2026 transaction — appears timely (no late filing indicated).
  • No 10b5-1 plan, tax-withholding sale, or immediate sale reported in this transaction.

Context

  • This was a compensatory RSU conversion (award), common for executive compensation; it is not a market purchase or sale and should not be read as a direct buy/sell signal. The filing also discloses outstanding stock options granted in 2024 with future vesting dates, but no option exercises or cashless sales were reported in this transaction.

Insider Transaction Report

Form 4
Period: 2026-02-04
Morcos Assaad A
VP, US Manufacturing
Transactions
  • Award

    Restricted stock units

    [F1][F2]
    2026-02-04+407407 total
    Exercise: $0.00Common shares, $2 par value (407 underlying)
Holdings
  • Restricted stock units

    [F2]
    Exercise: $0.00Common shares, $2 par value (681 underlying)
    681
  • Employee stock option (right to buy)

    [F3]
    Exercise: $132.40Common Shares, $2 par value per share (6,500 underlying)
    6,500
Footnotes (3)
  • [F1]Restricted stock units converted into common stock on a one-for-one basis.
  • [F2]Restricted stock units vest 3 years from the date of grant.
  • [F3]On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.
Signature
/s/ Caroline S Vaccariello, by power of attorney|2026-02-06

Documents

1 file
  • 4
    wk-form4_1770416896.xmlPrimary

    FORM 4